Donanemab (Anti-Amyloid Beta)
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research. MW : 145.36 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2833 |
| Sku # | A2833-1mg |
| Pricing | 1mg, $370.00 |